NEVVI Medicare utilization intelligence
or

← back

Provider profile

MUSLIMANI, ALAA MD

Medical Oncology · NPI 1881887826 · ROCK HILL, SC

1
Groups
55
Codes · 2024
135,281
Disclosed services

MUSLIMANI, ALAA is a Medical Oncology in ROCK HILL, SC, a member of 1 medical group, who billed 55 distinct codes to Medicare Part B in 2024.

Groups: THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY (CONCORD, NC)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

135,281
disclosed services
55
codes billed to Medicare Part B
Prior year · CY2023 160,697 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J9299 Injection, nivolumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9267 Injection, paclitaxel, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9264 Injection, paclitaxel protein-bound particles, 1 mg
J0897 Injection, denosumab, 1 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
Q5118 Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J0640 Injection, leucovorin calcium, per 50 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
J9190 Injection, fluorouracil, 500 mg
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
96372 Injection of drug or substance under skin or into muscle
83735 Magnesium level
J9045 Injection, carboplatin, 50 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
81003 Automated urinalysis test
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96417 Administration of additional new drug or substance into vein, 1 hour or less
83615 Lactate dehydrogenase (enzyme) level
96415 Administration of chemotherapy into vein, each additional hour
82150 Amylase (enzyme) level
83690 Lipase (fat enzyme) level
J1200 Injection, diphenhydramine hcl, up to 50 mg
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J3489 Injection, zoledronic acid, 1 mg
96374 Injection of drug or substance into vein
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
85007 Microscopic examination for white blood cells with manual cell count
96416 Administration of prolonged chemotherapy into vein
J3490 Unclassified drugs
96411 Administration of additional new drug or substance into vein using push technique
96409 Administration of chemotherapy into vein using push technique
84100 Phosphate level
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
85045 Red blood count, automated test
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99497 Advance care planning, first 30 minutes
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
36415 Insertion of needle into vein for collection of blood sample
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.